Similarly, in Alzheimer’s disease research, the integration of eQTL data with cerebrospinal fluid biomarker profiles highlighted crucial loci, including APOE and TMEM106B, thereby refining our understanding of AD pathogenesis and identifying potential therapeutic targets through the combination of genetic and molecular approaches [57]. This evidence concerns the gene APOE and Alzheimer disease.